首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1467781

2024-2032 年按類型、藥物類型、給藥途徑、配銷通路和地區分類的單純皰疹病毒治療市場報告

Herpes Simplex Virus Treatment Market Report by Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球單純皰疹病毒治療市場規模達26億美元。個人對各種 HSV 藥物的認知不斷提高、醫療保健支出增加以及透過線上和線下藥局廣泛獲得 HSV 藥物是推動市場的一些關鍵因素。

單純皰疹病毒（HSV）是一種傳染性病毒感染，透過唾液、精液和陰道分泌物傳播，引起水皰和潰瘍。它在個體中產生單純皰疹病毒 1 (HSV-1) 感染和單純皰疹病毒 2 (HSV-2) 感染。在潰瘍出現之前，它還會引起發燒、身體疼痛、淋巴結腫大、頭痛、刺痛、搔癢或口腔周圍灼熱感。它通常發生在性伴侶感染 HSV 或免疫功能低下的人群中。 HSV 可以透過服用一些抗病毒藥物來治愈，例如阿昔洛韋、泛昔洛韋和伐昔洛韋。也可以透過一些家庭療法來治療，例如熱敷或冷敷、蘆薈、小蘇打或玉米澱粉和水的糊狀物，以及壓碎的大蒜的混合物。 HSV 治療有助於降低病毒傳播的機會並降低爆發的頻率或嚴重程度。

單純皰疹病毒治療市場趨勢：

目前，全球性傳染病（STI）盛行率不斷上升，是支持市場成長的關鍵因素之一。此外，由於全世界個人對性健康的擔憂，對 HSV 治療的需求不斷增加，這也促進了市場的成長。除此之外，由於全球個人對 HSV 感染風險和併發症的認知不斷提高，對 HSV 治療的需求不斷成長，這對市場產生了積極影響。此外，對副作用減少、療效增強的新 HSV 治療方案的需求不斷成長，正在推動市場的成長。除此之外，不斷增加的醫療保健支出以及個人收入水準的上漲，為行業投資者提供了利潤豐厚的成長機會。此外，HSV 藥物透過全球線上和線下藥局的廣泛供應正在推動市場的成長。除此之外，個人對 HSV 治療方案的需求不斷增加，以預防嚴重併發症，如腦炎（腦部感染）或角膜炎（眼部感染），也促進了市場的成長。此外，單純皰疹病毒治療方案的不斷創新和各種藥物的批准正在加強市場的成長。

本報告回答的關鍵問題

全球單純皰疹病毒治療市場有多大？
2024-2032年全球單純皰疹病毒治療市場的預期成長率為何？
推動全球單純皰疹病毒治療市場的關鍵因素是什麼？
COVID-19 對全球單純皰疹病毒治療市場有何影響？
根據藥物類型，全球單純皰疹病毒治療市場的詳細情形如何？
根據給藥途徑，全球單純皰疹病毒治療市場的詳細情形如何？
基於配銷通路的全球單純皰疹病毒治療市場的詳細情形如何？
全球單純皰疹病毒治療市場的關鍵地區有哪些？
全球單純皰疹病毒治療市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Agenus Inc.
- Apotex Inc.
- Avet Pharmaceuticals Inc.
- Carlsbad Tech
- EPI Health LLC
- F. Hoffmann-La Roche Ltd
- Fresenius SE & Co. KGaA
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Merck & Co. Inc.
- Novartis AG
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.

簡介目錄圖表

Product Code: SR112024A5257

The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032. The growing awareness among individuals about various medications of HSV, increasing healthcare expenditure, and wide availability of HSV medications through online and offline pharmacy stores represent some of the key factors driving the market.

Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.

Herpes Simplex Virus Treatment Market Trends:

At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global herpes simplex virus treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, route of administration and distribution channel.

Type Insights:

Herpes Simples Virus-1 Infection

Herpes Simplex Virus-2 Infection

Others

The report has provided a detailed breakup and analysis of the herpes simplex virus treatment market based on the type. This includes herpes simples virus-1 infection, herpes simplex virus-2 infection, and others.

Drug Type Insights:

Acyclovir

Valacyclovir

Famciclovir

Others

A detailed breakup and analysis of the herpes simplex virus treatment market based on the drug type has also been provided in the report. This includes acyclovir, valacyclovir, famciclovir, and others. According to the report, acyclovir accounted for the largest market share.

Route of Administration Insights:

Oral

Injectable

Topical

A detailed breakup and analysis of the herpes simplex virus treatment market based on the route of administration has also been provided in the report. This includes oral, injectable, and topical. According to the report, oral accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacy

Drug Stores

Retail Stores

Online Pharmacy

A detailed breakup and analysis of the herpes simplex virus treatment market based on the distribution channel has also been provided in the report. This includes hospital pharmacy, drug stores, retail stores, and online pharmacy. According to the report, hospital pharmacy accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. How big is the global herpes simplex virus treatment market?
2. What is the expected growth rate of the global herpes simplex virus treatment market during 2024-2032?
3. What are the key factors driving the global herpes simplex virus treatment market?
4. What has been the impact of COVID-19 on the global herpes simplex virus treatment market?
5. What is the breakup of the global herpes simplex virus treatment market based on the drug type?
6. What is the breakup of the global herpes simplex virus treatment market based on the route of administration?
7. What is the breakup of the global herpes simplex virus treatment market based on the distribution channel?
8. What are the key regions in the global herpes simplex virus treatment market?
9. Who are the key players/companies in the global herpes simplex virus treatment market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Herpes Simplex Virus Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Herpes Simples Virus-1 Infection
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Herpes Simplex Virus-2 Infection
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Acyclovir
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Valacyclovir
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Famciclovir
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Topical
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacy
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Drug Stores
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Retail Stores
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Online Pharmacy
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Agenus Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Apotex Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 SWOT Analysis
- 15.3.3 Avet Pharmaceuticals Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Carlsbad Tech
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 EPI Health LLC
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 F. Hoffmann-La Roche Ltd
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
- 15.3.7 Fresenius SE & Co. KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 GlaxoSmithKline plc
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Glenmark Pharmaceuticals Limited
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Merck & Co. Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Novartis AG
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Sanofi S.A.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Teva Pharmaceutical Industries Ltd.
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis
- 15.3.14 Viatris Inc.
  - 15.3.14.1 Company Overview
  - 15.3.14.2 Product Portfolio
  - 15.3.14.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players

02-2729-4219

+886-2-2729-4219